Suzanne Lucash, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 57 E Main St, Suite 212, Westborough, MA 01581 Phone: 508-366-7461 Fax: 508-366-5018 |
Reliant Medical Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 900 Union St, Westborough, MA 01581 Phone: 508-856-9599 Fax: 508-871-0779 |
Suzanne Lucash, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 57 E Main St, Suite 212, Westborough, MA 01581 Phone: 508-366-7461 Fax: 508-366-5018 |
Ewa M. Mamber, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: Westborough State Hospital, Lyman Street, Westborough, MA 01581 Phone: 508-616-2835 |
Karin L Underkoffler, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 900 Union St, Westborough, MA 01581 Phone: 508-871-1799 Fax: 508-871-0779 |
Westborough Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1 E Main St, Westborough, MA 01581 Phone: 508-366-4500 Fax: 508-366-4522 |
Dr. Khuong Nguyen, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 1 E Main St, Westborough, MA 01581 Phone: 508-366-4500 |
Suzanne Lucash Optometrist Medicare: Medicare Enrolled Practice Location: 4 Lyman Street, Westborough, MA 01581 Phone: 508-366-7461 Fax: 508-366-5018 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces that it has reached an agreement with the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration to conduct additional clinical trials to confirm the clinical benefit of ProAmatine (midodrine HCl), a medicine approved in 1996 under Subpart H for the treatment of symptomatic orthostatic hypotension (SOH).
Many countries across the globe are experiencing a sharp surge in COVID-19 cases, with the total global case toll reaching more than 25.86 million. Face masks have become one of the most effective means to combat the virus spread, particularly if used in combination with regular hand hygiene and physical distancing.
Demand for real-time continuous data, including personal health information, early warning scores, and alerting when a patient's condition is deteriorating, is driving the market for complete monitoring systems in hospital and home care settings globally.
Longhorn Vaccines & Diagnostics today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ in CLIA high complexity laboratories. . The Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ is a ready-use assay that requires no mixing prior to use and has been authorized for use on the ABI 7500.
› Verified 9 days ago